In the given case the Dariah BHD Ltd has incurred heavy expenses on account of converting the riboflavin into chemical A & Chemical B
Total Expenditure incurred for this R & D is RM 96,000
But only Chemical B is developed with economic benefits towards the company therefore the Chemical A's R & D cost have no economic benefit towards the entity, therefore cost related to Chemical A should be directly debited to income statement.
50% of total amount is assumed to be used in R & D Expenditure of Chemical A, it Means 50% of 96,000 i.e RM 48,000 is required to charged off whereas remaining amount of RM 48,000 will be capitalized and to be charged to P& L in proportion of life of economic benefit from the use of Chemical B.
Total R & D Expenditure in development of Chemical B is RM 48,000 Plus RM 2,40,000 i.e 2,88,000. This amount would be capitalized & will be charged to P & L in next 5 Year of benefits
Total expenditure upto 31st December 2016 = 2,88,000
Total No. of Month = 60 Months
Life of project lapsed in current year ending 31st December 2016 = 7 Months
Amount to be charged off in current year is RM 48,000 (being R & D expenditure of Unsuccessful research Chemical A) + 288000*7/60 = 81,600
Amount to be capitalized is remaining balance of R & D Expenditure as on 31st December 2016 i.e 2,88,000 - 33,600 = RM 2,54,400
Its first year ot operation till 31 December 2016, Dariah Bhd. has been h eavily investing in res...